GPR137C Polyclonal Antibody

    • Catalog No.:YT1971
    • Applications:WB;IHC;IF;ELISA
    • Reactivity:Human;Rat;Mouse;
      • Target:
      • GPR137C
      • Gene Name:
      • GPR137C
      • Protein Name:
      • Integral membrane protein GPR137C
      • Human Swiss Prot No:
      • Q8N3F9
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human GPR137C. AA range:256-305
      • Specificity:
      • GPR137C Polyclonal Antibody detects endogenous levels of GPR137C protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IHC 1:100 - 1:300. IF 1:200 - 1:1000. ELISA: 1:10000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • GPR137C;TM7SF1L2;Integral membrane protein GPR137C;Transmembrane 7 superfamily member 1-like 2 protein
      • Observed Band(KD):
      • 45kD
      • Background:
      • similarity:Belongs to the GPR137 family.,
      • Function:
      • similarity:Belongs to the GPR137 family.,
      • Subcellular Location:
      • Lysosome membrane ; Multi-pass membrane protein .
      • Expression:
      • Melanoma,Small intestine,
      • Products Images
      • Western Blot analysis of various cells using GPR137C Polyclonal Antibody
      • Immunofluorescence analysis of MCF7 cells, using GPR137C Antibody. The picture on the right is blocked with the synthesized peptide.
      • Immunohistochemistry analysis of paraffin-embedded human brain tissue, using GPR137C Antibody. The picture on the right is blocked with the synthesized peptide.
      • Western blot analysis of lysates from HepG2 cells, using GPR137C Antibody. The lane on the right is blocked with the synthesized peptide.